Treatment of acrodermatitis continua of Hallopeau with adalimumab.
Ryan
C
C
Collins
P
P
Kirby
B
B
Rogers
S
S
D000169:Acrodermatitis / Q000188:drug therapy*; D000068879:Adalimumab; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018450:Disease Progression; D005260:Female; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D012907:Smoking / Q000009:adverse effects; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab